Arcutis Biotherapeutics develops topical therapies for chronic skin conditions, with a portfolio targeting psoriasis and atopic dermatitis.
We have all dealt with dandruff; they are surprisingly hard to get rid of. Sometimes, dandruff is not just an annoyance but ...
INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...
Skin is increasingly understood as a reflection of internal balance rather than a problem limited to the surface. Conditions such as psoriasis and eczema highlight this connection. Both are chronic, ...
Earning the 2025 Best of Georgia Award underscores Root Revival’s commitment to delivering results that are both visible and ...
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being treated with topical steroids are concerned about side effectsNearly 8 in 10 ...
Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, yet no 2 cases look alike, says Philip Mease, MD, director of rheumatology and research, Providence Swedish Medical Center, ...
As instances of scalp flaking increase and people scratch their heads in shame, dermatologists give some advice ...
Arcutis Biotherapeutics and Kowa Pharmaceuticals are cutting ties on their U.S. marketing partnership around Arcutis’ Zoryve ...
Under the terms of the Termination Agreement, Kowa will cease all sales and promotions of ZORYVE and Arcutis will not be required to make any further payments. The Company expects to remain cash flow ...
Seborrheic dermatitis is positively associated with a range of epithelial barrier diseases, including dermatologic, respiratory, gastrointestinal, and ocular diseases. Seborrheic dermatitis is ...
Please provide your email address to receive an email when new articles are posted on . Data suggest shared drivers in the pathogenesis of seborrheic dermatitis and other epithelial barrier diseases, ...